share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰製藥 | 4:持股變動聲明-高管 Bozic Carmen
美股SEC公告 ·  07/25 16:10
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. (VRTX) EVP and CMO, Carmen Bozic, completed a sale of 2,280 shares of company stock on July 24, 2024. The transaction was executed at a price of $488.46 per share, resulting in a total sale value of $1,113,688.80. Following the sale, Bozic's direct holdings in Vertex Pharmaceuticals totaled 25,539 shares. The sale took place through an open market transaction, as reported in the company's filing.
Vertex Pharmaceuticals Inc. (VRTX) EVP and CMO, Carmen Bozic, completed a sale of 2,280 shares of company stock on July 24, 2024. The transaction was executed at a price of $488.46 per share, resulting in a total sale value of $1,113,688.80. Following the sale, Bozic's direct holdings in Vertex Pharmaceuticals totaled 25,539 shares. The sale took place through an open market transaction, as reported in the company's filing.
福泰製藥公司(VRTX)執行副總裁兼首席醫學官卡門·博齊奇於2024年7月24日完成了對公司股票2280股的銷售。交易價格爲每股488.46美元,總銷售額爲1113688.80美元。在出售後,博齊奇在福泰製藥的直接持股總計25539股。此次交易是通過公開市場交易進行的,如公司備案所述。
福泰製藥公司(VRTX)執行副總裁兼首席醫學官卡門·博齊奇於2024年7月24日完成了對公司股票2280股的銷售。交易價格爲每股488.46美元,總銷售額爲1113688.80美元。在出售後,博齊奇在福泰製藥的直接持股總計25539股。此次交易是通過公開市場交易進行的,如公司備案所述。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息